Mitochondrial pyruvate supports lymphoma proliferation by fueling a non-canonical glutamine metabolism pathway
Preprint
Abstract
SUMMARY: The fate of pyruvate, which is modulated by the activity of the mitochondrial pyruvate carrier (MPC), is a defining metabolic feature in many cancers. Diffuse large B-cell lymphomas (DLBCLs) are a genetically and metabolically heterogeneous cancer. Although MPC expression and activity differed between DLBCL subgroups, mitochondrial pyruvate was uniformly consumed by glutamate pyruvate transaminase 2 (GPT2) to support α-ketoglutarate production as part of glutaminolysis. This led us to discover that glutamine exceeds pyruvate as a carbon source for the tricarboxylic acid (TCA) cycle in DLBCLs. Furthermore, we found that MPC inhibition unexpectedly leads to decreased glutaminolysis, which is contrary to previous observations in other cell types. We also discovered that MPC inhibition and depletion only decreased DLBCL proliferation in an extracellular matrix (ECM) environment and in vivo xenografts, but not in the typical DLBCL suspension environment. We also have found that the metabolic profile of DLBCL cells in ECM is markedly different from cells in suspension environment. Thus, we report that besides the canonical glutamate dehydrogenase (GDH)-mediated glutaminolysis, the non-canonical GPT2 mediated consumption and assimilation of glutamine and pyruvate in DLBCLs enables their proliferation in an extracellular environment-dependent manner. HIGHLIGHTS: Glutamine, but not glucose, is a major carbon source for the tricarboxylic acid cycle in diffuse large B-cell lymphomas. Mitochondrial pyruvate supports glutaminolysis in diffuse large B-cell lymphomas by supplying pyruvate for glutamate pyruvate transaminase 2-mediated α -ketoglutarate production. Mitochondrial pyruvate carrier inhibition leads to decreased glutaminolysis in diffuse large B-cell lymphomas. α -ketoglutarate production is important for diffuse large B-cell lymphoma proliferation in a solid extracellular matrix environment. Mitochondrial pyruvate carrier activity supports diffuse large B-cell lymphoma proliferation in a solid extracellular matrix environment and in mouse xenografts.Keywords
This publication has 39 references indexed in Scilit:
- A Mitochondrial Pyruvate Carrier Required for Pyruvate Uptake in Yeast, Drosophila , and HumansScience, 2012
- Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxiaNature, 2011
- Reductive carboxylation supports growth in tumour cells with defective mitochondriaNature, 2011
- High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapyHaematologica, 2011
- Ammonia Derived from Glutaminolysis Is a Diffusible Regulator of AutophagyScience Signaling, 2010
- Aggressive LymphomasNew England Journal of Medicine, 2010
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Targeting angiogenesis: a novel, rational therapeutic approach for non-Hodgkin lymphomaLeukemia & Lymphoma, 2009
- Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approachBlood, 2005
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000